Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07260253 · ClinicalTrials.gov registry record · NA

Remotely-supervised Neuromodulation in PPA

A NA study of Primary Progressive Aphasia(PPA) and Logopenic Progressive Aphasia (LPA), sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT07260253 is a NA study of Primary Progressive Aphasia(PPA) and Logopenic Progressive Aphasia (LPA) that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 80 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07260253, a NA study of Primary Progressive Aphasia(PPA) and Logopenic Progressive Aphasia (LPA), is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to learn whether remotely-supervised transcranial direct-current stimulation (RS-tDCS) can improve speech and language treatments for individuals with logopenic variant primary progressive aphasia (lvPPA). tDCS is a form of brain stimulation where a low-level electrical current is delivered to the brain through electrodes placed on the head. The main questions the trial aims to answer are: * Is it feasible to do RS-tDCS with virtual speech therapy? * How can brain magnetic resonance imaging scans (MRIs) predict how well someone will benefit from RS-tDCS with virtual speech therapy? Researchers will compare active RS-tDCS stimulation to sham stimulation (where there is no active stimulation, but participants feel stimulation effects at the beginning and end of the session). Participants will: * Travel to either the University of California, San Francisco (UCSF) or the University of Texas at Austin (UT Austin) one time for in-person testing, an MRI scan, and training on how to use the RS-tDCS equipment * Meet with a speech-language pathologist for pre-treatment testing on Zoom for 2 weeks * Participate in speech-language therapy and independent practice on Zoom 5 days a week for 4 weeks, using either active tDCS stimulation or sham * Complete post-treatment testing on Zoom for 1-2 weeks * Complete follow-up testing 2 months after completion of treatment

Interventions

  • BEHAVIORAL Lexical Retrieval Cascade Treatment
  • DEVICE Remotely Supervised Transcranial Direct Current Stimulation

Study Locations (2)

California

  • UCSF Memory and Aging Cener - San Francisco

Texas

  • University of Texas - Austin

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-01
Est. Completion 2029-08
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT07260253

The ClinicalTrials.gov registry entry for NCT07260253 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Primary Progressive Aphasia(PPA) appearing as the primary indexed condition, and to 2 interventions - of which Lexical Retrieval Cascade Treatment is the first listed.

NCT07260253 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.

Frequently Asked Questions

What is clinical trial NCT07260253 about?

NCT07260253 is a clinical study titled "Remotely-supervised Neuromodulation in PPA". The goal of this clinical trial is to learn whether remotely-supervised transcranial direct-current stimulation (RS-tDCS) can improve speech and language treatments for individuals with logopenic variant primary progressive aphasia (lvPPA). tDCS is a form of brain stimulation where a low-level elect...

What is the current status of trial NCT07260253?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-01. Estimated completion is 2029-08.

What conditions does trial NCT07260253 study?

This clinical trial studies the following conditions: Primary Progressive Aphasia(PPA), Logopenic Progressive Aphasia (LPA), Progressive Aphasia, Logopenic Variant Primary Progressive Aphasia, Logopenic Variant of Primary Progressive Aphasia (LPA).

What interventions are being tested in trial NCT07260253?

The interventions under investigation include: Lexical Retrieval Cascade Treatment (BEHAVIORAL), Remotely Supervised Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT07260253?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07260253 being conducted?

This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Progressive Aphasia(PPA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.